Progen Co., Ltd. (XKON:296160)
5,140.00
-150.00 (-2.84%)
At close: Apr 24, 2026
Progen Market Cap
Progen has a market cap or net worth of 79.03 billion as of April 24, 2026. Its market cap has increased by 16.43% in one year.
Market Cap
79.03B
Enterprise Value
n/a
Revenue
450.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,140.00
Market Cap Chart
Since November 15, 2023, Progen's market cap has increased from 46.33B to 79.03B, an increase of 70.59%. That is a compound annual growth rate of 24.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 79.03B | -31.83% |
| Dec 30, 2025 | 115.93B | 28.30% |
| Dec 30, 2024 | 90.36B | 9.39% |
| Dec 28, 2023 | 82.60B | 78.30% |
| Nov 15, 2023 | 46.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CHA Vaccine Research Institute | 96.98B |
| Quratis | 95.42B |
| CTCBIO | 93.12B |
| Choong Ang Vaccine Laboratory | 92.70B |
| SunBio,Inc. | 89.26B |
| Shaperon | 82.36B |
| Naturalendo Tech | 82.09B |
| PanGen Biotech | 81.24B |